| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.29 | 0.009 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |